Clinical trial
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary…
NCT00319111 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00319111 |
|---|---|
| Title | Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) |
| Official title | Long-term Open-label Extension Study in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Who Completed Protocol AC-052-366 (BENEFIT, NCT00313222) |
| Acronym | BENEFIT OL |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | bosentan |
| Enrollment | 151 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 4, 2025 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: